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BACKGROUND:  
Digital PCR (dPCR) has long been proposed as an alternative absolute quantification method to 
current quantitative real-time PCR (qPCR). With recent technological developments, dPCR is now 
possible at high throughput and at limited costs. As an example, Bio-Rad recently introduced the 
QX100™ Droplet Digital™ PCR Platform (ddPCR; Fig. 1). DPCR is believed to be a more 
accurate absolute quantification method compared to qPCR as dPCR does not rely on PCR 
efficiency for accurate quantification. Consequently, this technique forms a promising tool for HIV 
research and multiple applications are currently being investigated.  
In contrast to qPCR, dPCR does not rely on the kinetics of the PCR reactions. As long as 
sufficient fluorescent signal is obtained in positive replicates (droplets) then accurate quantification 
can proceed. This additional advantage of dPCR enables a high flexibility of assay design and 
cycling conditions. 
PROBLEM STATEMENT: 
Due to the high variability in HIV-1 variants within and between patients the development of 
assays that accurately detect HIV sequences is complicated. Recently, Van Der Sluis et al. (2013, 
J Virol Methods 187:94-102) developed a set of primers and probes that specifically target a 
highly conserved region in the HIV genome of all recorded HIV-1 variants. However, due to the 
small sequence available for assay design, the probe is characterized by a low melting 
temperature. Initial validation by a gradient ddPCR with decreasing annealing temperatures 
revealed that ddPCR for this assay is only possible at temperatures lower then 55°C (Fig 2). 
Figure 2: Dot plot output of the gradient ddPCR. 
Negative droplets have a background fluorescent 
signal, here between 150 and 400. Positive 
droplets have higher fluorescence. Absolute 
quantification is based on the ratio of positive 
versus negative droplets.  
In order to calculate this ratio, a treshold should 
be set based on the negative population. 
However, as can be observed on the current plot, 
the positive population cannot be distinguished 
unambiguously from the negative droplets, 
hampering quantification even at temperatures 
lower than 55°C. We hypothesized that the low 
positive fluorescence was due to the low melting 
temperature of the probe hampering efficient 
hydrolysis 
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DISCUSSION:  
New diagnostic tools for HIV disease monitoring in virologically well suppressed patients are 
required in order to guide the development and use of new therapeutic strategies. Digital PCR is 
proposed as a promising technology for HIV DNA and RNA quantification as it provides a high 
quantitative accuracy at low levels of target nucleic acids.  
The present work indicates that the high flexibility of assay design is an additional asset for the 
use of ddPCR. This will allow the development of assays specific to a larger variety of in vivo HIV 
variants, allowing a better assessment between patients infected with dissimilar HIV variants. 
CONCLUSIONS:  
- Digital PCR forms a promising technology for monitoring HIV DNA in 
patient samples. 
- The digital droplet PCR technology allows a high flexibility in assay design 
without losing quantitative accuracy and specificity.  
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OBJECTIVE: 
A strategy was investigated to maintain high reaction specificity, while allowing accumulation of 
fluorescent signal for quantification by using a two stage touchdown PCR.  
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Figure 3: A) Schematic representation of the two stage touchdown procedure. The first 30 cycle are performed at 
stringent annealing temperature (Ta), the second round of 9 cycles at lower temperature. B) dot plot outputs of 
four different touchdown procedures: 1: 30X 58°C & 6X 50°C; 2: 33X 58°C & 6X 50°C, 3: 24x 58°C & 15x 50°C, 
4: 30x 58°C & 9x 50°C. The distinction of positive versus negative droplets was optimal at condition 4. 
Validation of the touchdown ddPCR 
To validate the quantitative accuracy of the ddPCR, a two-fold standard dilution series of in vitro 
infected cells with HIV was prepared, with infection levels similar to observed in vivo infection 
levels. 
Subsequently, HIV DNA was quantified in peripheral blood mononuclear cells (PBMCs) from HIV-
infected patients to provide proof of concept that this method works on patient derived DNA . An 
internal reference gene (RPP30; table 1) was used to enable normalization of sample inputs. 
PBMCs from 16 patients were procured. These consisted of 8 therapy naïve viremic or elite 
controllers and 8 samples from patients on therapy. 
Figure 1: Schematic representaion of the ddPCR workflow. First droplets of PCR mix with primers, probes and 
sample are made in an oil suspension. These droplets form picoliter scale replicate PCR reactions. Fluorescence 
is subsequently measured in each droplet by flow cytometery. Finally, Poisson calculation of positive versus 
negative droplets enables absolute quantification of input DNA without the requirement of a standard curve. 
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Annealing temperature 
METHODS & RESULTS: 
Initial ddPCR tests were performed on plasmids containing the HIV-1 derived lab strain NL4-3 
sequence. Different touchdown strategies were compared and quantification of plasmids was 
correlated to quantification by standard ddPCR using primers and probes specific for the NL4-3 
sequence (Table 1).  
The two stage touchdown protocols (Fig. 3) consisted of a first set of stringent PCR conditions 
(58°C), allowing specific amplification. Subsequently, the annealing temperature was lowered (50°
C) to allow optimal fluorescent accumulation.  
A B 
name  sequence gene Ta °C nM  
HIVPf forward GCCTCAATAAAGCTTGCCTTGA HIV-1 58 200 
HIVPr reverse GGGCGCCACTGCTAGAGAT HIV-1 58 200 
HIVPpr probe GTA[a/t/g]CTAGAGATCCCTCAGA HIV-1 <55 200 
HIVNL4.3f forward TGTGTGCCCGTCTGTTGTGT HIV-1 NL4-3 58 200 
HIVNL4.3R reverse GAGTCCTGCGTCGAGAGAGC HIV-1 NL4-3 58 200 
HIVNL4.3pr probe 5’-FAM-CAGTGGCGCCCGAACAGGGA-TAMRA-3’ HIV-1 NL4-3 58 200 
RnasePf forward AGATTTGGACCTGCGAGCG RPP30 58 200 
RnasePR reverse GAGCGGCTGTCTCCACAAGT RPP30 58 200 
RnaseP probe probe /5'HEX/TTCTGACCTGAAGGCTCTGCGCG/3'IABkFQ/ RPP30 58 200 
Table 1: Primers and probes used for ddPCR detection  
Touchdown ddPCR 
The comparison of different touchdown procedures revealed that the most optimal procedure 
consists of 30 PCR cycles at stringent conditions, allowing specific PCR amplification. 
Subsequently, 9 PCR cycles at more relaxed conditions were adequate to accumulate sufficient 
fluorescent signal to enable maximal discrimination of positive versus negative droplets. 
Figure 2: A) Quantification of a 2-fold dilution series in duplicate ddPCR reactions of DNA from infected cells, 
revealing quantitative accuracy of ddPCR measurements B) HIV DNA copies per million PBMCs in the 16 
patients. No significant difference was observed between therapy naive viremic and elite controllers (TN), and 
between patients on highly active antiretroviral therapy (HAART).  
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